Skip to main content

Table 1 Summary of meta-regression analysis using dosage and duration as covariates on appropriate cardiometabolic biomarkers (i.e. ≥ 10 RCTs)

From: Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials

Moderator variable

p value

Meta-regression of moderator variable vs. effect size

Low density lipoprotein

 Duration

0.85

Slope 0.00, 95% CI − 0.01 to 0.01, df = 27

 Dosage

0.14

Slope 0.03, 95% CI − 0.01 to 0.07, df = 27

Triglycerides

 Duration

0.35

Slope 0.01, 95% CI − 0.01 to 0.01, df = 31

 Dosage

0.87

Slope -0.00, 95% CI − 0.07 to 0.08, df = 31

Glycated haemoglobin

 Duration

0.11

Slope 0.01, 95% CI − 0.00 to 0.02, df = 32

 Dosage

0.55

Slope 0.03, 95% CI − 0.07 to 0.13, df = 32